Psoriasiform lesions as a side effect of SGLT-2 therapy

Psoriasiform lesions as a side effect of SGLT-2 therapy

SGLT-2 inhibitors (flozins) are one of the new classes of anti-diabetic drugs, used from 2012. They are highly recommended in case of intolerance or contraindication of metformin, but in Poland they are used usually as third-line drug after metformin and sulfonylurea. They growing popularity is cau...

Full description

Bibliographic Details
Main Authors: Jakub Krzysztof Gałązka, Łukasz Domagalski, Piotr Homa, Zofia Hoffman
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2023-01-01
Series:Quality in Sport
Subjects:
flozins
SGLT-2 inhibitors
psoriasis
diabetes
diabetic kidney disease
diabetology
Online Access:https://apcz.umk.pl/QS/article/view/41832

Similar Items

Similar Items